Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...
Space-based solar power advances with microwave and laser transmission, orbital assembly, and cost reductions, aiming for ...
Scientists have unveiled a new way to capture ultra-sharp optical images without lenses or painstaking alignment. The ...
January 12, 2026 • Malaysia and Indonesia have become the first countries to block Grok, the artificial intelligence chatbot developed by Elon Musk's xAI, after authorities said it was being misused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback